Published in Scand J Infect Dis on January 01, 2008
Biofilm formation by Staphylococcus aureus isolates from skin and soft tissue infections. Curr Microbiol (2015) 0.84
Staphylococcus aureus carriage among GPs in The Netherlands. Br J Gen Pract (2010) 0.81
First documented case of a Staphylococcus lugdunensis strain carrying the mecA gene in Northern Europe. Infect Ecol Epidemiol (2011) 0.77
The mPEG-PCL Copolymer for Selective Fermentation of Staphylococcus lugdunensis Against Candida parapsilosis in the Human Microbiome. J Microb Biochem Technol (2016) 0.75
Redefining extended-spectrum beta-lactamases: balancing science and clinical need. J Antimicrob Chemother (2008) 2.88
Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet (2012) 2.35
Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob Agents Chemother (2003) 1.89
Dissemination of Escherichia coli with CTX-M type ESBL between humans and yellow-legged gulls in the south of France. PLoS One (2009) 1.87
Dissemination of multidrug-resistant bacteria into the Arctic. Emerg Infect Dis (2008) 1.74
Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis. Bull World Health Organ (2012) 1.60
Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis. J Antimicrob Chemother (2009) 1.52
Intrafamilial spread of highly virulent staphylococcus aureus strains carrying the gene for Panton-Valentine leukocidin. Scand J Infect Dis (2002) 1.46
[Time to abandon "the house wine". Stop for uncritical empiric use of cefuroxime]. Lakartidningen (2009) 1.43
The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada. J Antimicrob Chemother (2006) 1.40
Breakpoints for susceptibility testing should not divide wild-type distributions of important target species. Antimicrob Agents Chemother (2009) 1.39
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med (2015) 1.34
Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. J Antimicrob Chemother (2007) 1.32
Trimethoprim and enterococci in urinary tract infections: new perspectives on an old issue. J Antimicrob Chemother (2008) 1.16
Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J Antimicrob Chemother (2008) 1.13
Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella spp. from Norway and Sweden. Diagn Microbiol Infect Dis (2010) 1.02
Molecular characterisation of trimethoprim resistance in Escherichia coli and Klebsiella pneumoniae during a two year intervention on trimethoprim use. PLoS One (2010) 0.98
'Pre-emptive culturing' will improve the chance of 'getting it right' when empirical therapy of urinary tract infections fails. J Antimicrob Chemother (2009) 0.97
Asymptomatic bacteriuria in a population of elderly in municipal institutional care. Scand J Prim Health Care (2002) 0.94
Sequence types and plasmid carriage of uropathogenic Escherichia coli devoid of phenotypically detectable resistance. J Antimicrob Chemother (2011) 0.94
Mannitol salt agar-cefoxitin combination as a screening medium for methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2005) 0.91
High genetic diversity of nitrofurantoin- or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread. J Antimicrob Chemother (2013) 0.89
Setting interpretive breakpoints for antimicrobial susceptibility testing using disk diffusion. Int J Antimicrob Agents (2011) 0.89
Antibiotic stewardship: a call for action by the urologic community. Eur Urol (2013) 0.87
Biofilm formation by Staphylococcus aureus isolates from skin and soft tissue infections. Curr Microbiol (2015) 0.84
Antibiotic use and Escherichia coli resistance trends for quinolones and cotrimoxazole in Sweden. Scand J Infect Dis (2002) 0.83
Professional challenges and opportunities in clinical microbiology and infectious diseases in Europe. Lancet Infect Dis (2011) 0.81
Antibiotic resistance among Campylobacter jejuni/coli strains acquired in Sweden and abroad: a longitudinal study. Scand J Infect Dis (2003) 0.80
Extended antimicrobial resistance screening of the dominant faecal Escherichia coli and of rare resistant clones. Int J Antimicrob Agents (2005) 0.77
Effect of excluding duplicate isolates of Escherichia coli and Staphylococcus aureus in a 14 year consecutive database. J Antimicrob Chemother (2007) 0.77
[New guidelines for vancomycin in staphylococcal infections]. Lakartidningen (2010) 0.75
Searching High and Low: Call for a Joint European Society for Paediatric Infectious Diseases-European Committee on Antimicrobial Susceptibility Testing Survey on Dosage of Antibacterial Agents in Children-Part One. Pediatr Infect Dis J (2022) 0.75
National dissemination of EUCAST guidelines is a shared responsibility. Clin Microbiol Infect (2020) 0.75
Living with extended-spectrum β-lactamase: a qualitative study of patient experiences. Am J Infect Control (2013) 0.75
Developments in the recent past--hospital hygiene and antimicrobials. Medical Microbiology: a tool in control of health-care-associated infections. APMIS (2007) 0.75